Royal Bank of Canada Forecasts Strong Price Appreciation for agilon health (NYSE:AGL) Stock

agilon health (NYSE:AGL) had its price target raised by Royal Bank of Canada from $3.00 to $3.50 in a report issued on Wednesday,Benzinga reports. They currently have an outperform rating on the stock.

A number of other research analysts have also recently weighed in on the stock. Stifel Nicolaus lifted their price objective on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a report on Wednesday. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a report on Wednesday. Macquarie began coverage on agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective on the stock. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Finally, William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $3.95.

agilon health Price Performance

NYSE:AGL opened at $3.12 on Wednesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a 50 day moving average price of $2.96 and a 200-day moving average price of $3.03. agilon health has a 1-year low of $1.50 and a 1-year high of $7.73. The firm has a market cap of $1.29 billion, a price-to-earnings ratio of -3.32 and a beta of 0.66.

Insider Transactions at agilon health

In other agilon health news, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction on Friday, December 13th. The stock was bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director John William Wulf bought 45,000 shares of the stock in a transaction dated Thursday, December 5th. The shares were bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 77,500 shares of company stock valued at $169,600. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

A number of institutional investors have recently bought and sold shares of AGL. Capital International Investors grew its stake in shares of agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after buying an additional 9,346,295 shares during the period. Millennium Management LLC lifted its holdings in agilon health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after acquiring an additional 4,706,357 shares during the last quarter. Citigroup Inc. lifted its holdings in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the last quarter. Algert Global LLC grew its position in agilon health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after acquiring an additional 1,924,157 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after acquiring an additional 1,498,524 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.